Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Umar Farooq, MD, Matthew J Maurer, MS, Stephen M Ansell, MD, PhD, Tasha Lin, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD, David J. Inwards, MD, William Macon, MD, Syrbu Sergei, MD, James Cerhan, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Thomas M. Habermann, MD, Carrie A. Thompson, MD

Blood (2015) 126 (23): 2683.

https://doi.org/10.1182/blood.V126.23.2683.2683

Published: 2015

Journal Articles

Incidence and Outcomes of Treatment Refractory Diffuse Large B-Cell Lymphoma in the Immunochemotherapy Era

Matthew J Maurer, MS, Carrie A. Thompson, MD, Umar Farooq, MD, Tasha Lin, MD, Grzegorz S. Nowakowski, MD, Yi Lin, MD PhD, Ivana Micallef, MD, Anne Novak, PhD, William Macon, MD, Sergei Syrbu, MD, James Cerhan, MD PhD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Stephen Ansell, MD PhD, Brian K Link, MD

Blood (2015) 126 (23): 3992.

https://doi.org/10.1182/blood.V126.23.3992.3992

Published: 2015

Journal Articles

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Luis Porrata, MD, Kay Ristow, Ellen D. McPhail, MD, William Macon, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD, Svetomir Markovic, MD PhD, Thomas M. Habermann, MD

Blood (2015) 126 (23): 3885.

https://doi.org/10.1182/blood.V126.23.3885.3885

Published: 2015

Journal Articles

Natural History of Central Nervous System Relapse in Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era

Gita Thanarajasingam, MD, Matthew J Maurer, MS, Umar Farooq, MD, Patrick B. Johnston, MD PhD, Carrie Thompson, MD, Stephen Ansell, MD PhD, Luis Porrata, MD, William Macon, MD, Sergei Syrbu, MD, James Cerhan, MD PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Brian K Link, MD, Grzegorz S. Nowakowski, MD

Blood (2015) 126 (23): 1456.

https://doi.org/10.1182/blood.V126.23.1456.1456

Published: 2015

Journal Articles

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

Matthew J Maurer, MS, Fredrik Ellin, MD MSc, James Cerhan, MD PhD, Stephen Ansell, MD PhD, Brian K Link, MD, Mats Jerkeman, MD PhD, Karin E Smedby, MD PhD, Carrie A. Thompson, MD, William Macon, MD, Sergei Syrbu, MD, Susan L. Slager, PhD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Thomas Relander, MD PhD, Andrew L Feldman, MD

Blood (2015) 126 (23): 1501.

https://doi.org/10.1182/blood.V126.23.1501.1501

Published: 2015

Journal Articles

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Thomas E. Witzig, Craig Reeder, Jing Jing Han, Betsy LaPlant, Mary Stenson, Han W. Tun, William Macon, Stephen M. Ansell, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Joseph P. Colgan, Svetomir Markovic, Grzegorz S. Nowakowski, Mamta Gupta

Blood (2015) 126 (3): 328–335.

https://doi.org/10.1182/blood-2015-02-629543

Published: 2015

Includes: Supplemental data

Journal Articles

Characterization of the Copy-Number Changes In Primary CNS Lymphomas (PCNSL) by High-Resolution Array-Based Comparative Genomic Hybridization

Esteban Braggio, Brian Patrick O'Neill, William Macon, Maria Beatriz Lopes, David Schiff, Rafael Fonseca

Blood (2010) 116 (21): 995.

https://doi.org/10.1182/blood.V116.21.995.995

Published: 2010

Journal Articles

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Ivana N Micallef, MD, Joseph Colgan, MD, Thomas M. Habermann, MD, David James Inwards, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Mamta Gupta, Ph.D, Sergei I Syrbu, MD, Paul Kurtin, MD, William Macon, MD, Thomas E. Witzig, MD

Blood (2010) 116 (21): 4136.

https://doi.org/10.1182/blood.V116.21.4136.4136

Published: 2010

NARROW

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Incidence and Outcomes of Treatment Refractory Diffuse Large B-Cell Lymphoma in the Immunochemotherapy Era

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Natural History of Central Nervous System Relapse in Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Characterization of the Copy-Number Changes In Primary CNS Lymphomas (PCNSL) by High-Resolution Array-Based Comparative Genomic Hybridization

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only